Cargando…

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs

We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farooq, Hamzah Z., Cirillo, Daniela M., Hillemann, Doris, Wyllie, David, van der Werf, Marieke J., Ködmön, Csaba, Nikolayevskyy, Vlad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920658/ https://www.ncbi.nlm.nih.gov/pubmed/33622487 http://dx.doi.org/10.3201/eid2703.204418

Ejemplares similares

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2016)

Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017–2019: an ECDC pilot study
por: Tagliani, Elisa, et al.
Publicado: (2021)

European Union training programme for tuberculosis laboratory experts: design, contribution and future direction
por: Raftery, Philomena, et al.
Publicado: (2020)

Whole-Genome Sequencing as Tool for Investigating International Tuberculosis Outbreaks: A Systematic Review
por: van der Werf, Marieke J., et al.
Publicado: (2019)

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area
por: Anthony, R. M., et al.
Publicado: (2022)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries
por: Hillemann, Doris, et al.
Publicado: (2013)

Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015
por: Ködmön, Csaba, et al.
Publicado: (2017)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries
por: Andrés, Marta, et al.
Publicado: (2019)

Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014
por: Sotgiu, Giovanni, et al.
Publicado: (2017)

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles
por: van der Werf, Marieke J., et al.
Publicado: (2016)

MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Using QIAxcel Technology: A Multicentre Evaluation Study
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2016)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates
por: Hillemann, Doris, et al.
Publicado: (2018)

Associations between Mycobacterium tuberculosis Strains and Phenotypes
por: Brown, Timothy, et al.
Publicado: (2010)

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023)

Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study
por: Mathys, V., et al.
Publicado: (2018)

Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany
por: Sonnenkalb, Lindsay, et al.
Publicado: (2021)

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015
por: Hollo, V, et al.
Publicado: (2017)

Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates
por: Broda, Agnieszka, et al.
Publicado: (2018)

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting
por: Andres, Söenke, et al.
Publicado: (2019)

Zinc limitation triggers anticipatory adaptations in Mycobacterium tuberculosis
por: Dow, Allexa, et al.
Publicado: (2021)

Comparing the Metabolic Capabilities of Bacteria in the Mycobacterium tuberculosis Complex
por: Fieweger, Rachael A., et al.
Publicado: (2019)

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014
por: Karo, Basel, et al.
Publicado: (2019)

Accuracy of the QIAxcel Automated System for MIRU-VNTR Genotyping of Mycobacterium tuberculosis in Two Limited Resource Settings
por: Tafaj, Silva, et al.
Publicado: (2020)

Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan
por: Shuaib, Yassir A., et al.
Publicado: (2020)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
por: Kalokhe, Ameeta S., et al.
Publicado: (2012)

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid
por: Bateson, Anna, et al.
Publicado: (2022)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

Discriminatory Ability of Hypervariable Variable Number Tandem Repeat Loci in Population-based Analysis of Mycobacterium tuberculosis Strains, London, UK
por: Velji, Preya, et al.
Publicado: (2009)

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from saliva
por: Hansen, Julia, et al.
Publicado: (2022)

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains
por: Kremer, Kristin, et al.
Publicado: (2009)

Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis
por: Ayelign, Birhanu, et al.
Publicado: (2019)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Genome-Wide Discovery of Small RNAs in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2012)

Mycobacterium tuberculosis Transcriptome Profiling in Mice with Genetically Different Susceptibility to Tuberculosis
por: Skvortsov, T.A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_plbufu7t6ogod1ll5i8ab3l1j7